HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 100 filers reported holding HARVARD BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,036,060 | -33.9% | 2,117,916 | -1.6% | 0.00% | – |
Q1 2024 | $9,125,104 | -18.9% | 2,152,147 | +2.4% | 0.00% | – |
Q4 2023 | $11,248,755 | +26.7% | 2,102,571 | +1.8% | 0.00% | – |
Q3 2023 | $8,876,929 | -17.6% | 2,064,402 | +5.2% | 0.00% | – |
Q2 2023 | $10,771,474 | +47.1% | 1,962,017 | +12.5% | 0.00% | – |
Q1 2023 | $7,324,783 | +110.2% | 1,743,996 | +38.7% | 0.00% | – |
Q4 2022 | $3,484,100 | -11.5% | 1,257,798 | -18.2% | 0.00% | – |
Q3 2022 | $3,938,000 | -28.9% | 1,538,283 | 0.0% | 0.00% | – |
Q2 2022 | $5,538,000 | -53.7% | 1,538,283 | -20.1% | 0.00% | – |
Q1 2022 | $11,952,000 | -0.6% | 1,924,517 | +12.8% | 0.00% | – |
Q4 2021 | $12,025,000 | -4.4% | 1,705,685 | -5.3% | 0.00% | – |
Q3 2021 | $12,576,000 | -21.6% | 1,801,705 | -6.4% | 0.00% | – |
Q2 2021 | $16,043,000 | +92.9% | 1,925,868 | +26.4% | 0.00% | – |
Q1 2021 | $8,318,000 | +5.7% | 1,523,327 | -16.9% | 0.00% | – |
Q4 2020 | $7,866,000 | +29.0% | 1,833,716 | -9.5% | 0.00% | – |
Q3 2020 | $6,099,000 | -8.4% | 2,026,097 | -5.6% | 0.00% | – |
Q2 2020 | $6,657,000 | +50.4% | 2,147,269 | +7.2% | 0.00% | – |
Q1 2020 | $4,426,000 | -0.7% | 2,002,899 | +37.1% | 0.00% | – |
Q4 2019 | $4,457,000 | +10.1% | 1,461,199 | +11.0% | 0.00% | – |
Q3 2019 | $4,049,000 | +13.0% | 1,316,599 | -26.5% | 0.00% | – |
Q2 2019 | $3,584,000 | -54.7% | 1,791,842 | -2.4% | 0.00% | – |
Q1 2019 | $7,916,000 | +35.2% | 1,836,648 | -0.3% | 0.00% | – |
Q4 2018 | $5,857,000 | -38.4% | 1,841,800 | +1.6% | 0.00% | – |
Q3 2018 | $9,515,000 | +14.2% | 1,812,401 | +16.3% | 0.00% | – |
Q2 2018 | $8,334,000 | +22.3% | 1,557,908 | +14.3% | 0.00% | – |
Q1 2018 | $6,817,000 | +33.9% | 1,363,406 | -11.6% | 0.00% | – |
Q4 2017 | $5,090,000 | -13.7% | 1,542,534 | -1.9% | 0.00% | – |
Q3 2017 | $5,899,000 | +50.2% | 1,573,069 | +2.1% | 0.00% | – |
Q2 2017 | $3,927,000 | -0.3% | 1,540,021 | +1.7% | 0.00% | – |
Q1 2017 | $3,937,000 | -13.5% | 1,514,439 | +1.5% | 0.00% | – |
Q4 2016 | $4,550,000 | +12.4% | 1,491,999 | +0.3% | 0.00% | – |
Q3 2016 | $4,047,000 | -1.0% | 1,488,123 | +4.1% | 0.00% | – |
Q2 2016 | $4,087,000 | -8.9% | 1,428,910 | -3.8% | 0.00% | – |
Q1 2016 | $4,486,000 | -9.8% | 1,485,453 | +3.6% | 0.00% | – |
Q4 2015 | $4,975,000 | -96.5% | 1,433,804 | -77.9% | 0.00% | -100.0% |
Q3 2015 | $142,421,000 | +2153.1% | 6,491,476 | +485.3% | 0.01% | – |
Q2 2015 | $6,321,000 | +3.0% | 1,109,041 | +5.2% | 0.00% | – |
Q1 2015 | $6,134,000 | +5.8% | 1,053,930 | +3.1% | 0.00% | – |
Q4 2014 | $5,795,000 | +42.0% | 1,021,950 | +2.5% | 0.00% | – |
Q3 2014 | $4,080,000 | -1.6% | 997,425 | +9.5% | 0.00% | – |
Q2 2014 | $4,145,000 | -6.0% | 911,084 | -2.0% | 0.00% | – |
Q1 2014 | $4,408,000 | +5.3% | 929,823 | +4.4% | 0.00% | – |
Q4 2013 | $4,187,000 | -7.1% | 890,852 | +3.9% | 0.00% | – |
Q3 2013 | $4,509,000 | +13.2% | 857,214 | +1.8% | 0.00% | – |
Q2 2013 | $3,984,000 | – | 842,215 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AMH Equity Ltd | 2,199,922 | $6,269,778 | 8.31% |
272 Capital LP | 1,535,820 | $4,377,087 | 2.19% |
Meros Investment Management, LP | 835,213 | $2,380,357 | 1.13% |
Harvey Partners, LLC | 2,557,500 | $7,288,875 | 0.88% |
Acuitas Investments, LLC | 407,343 | $1,160,928 | 0.62% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,772,339 | $7,901,166 | 0.46% |
BARD ASSOCIATES INC | 296,995 | $846,436 | 0.32% |
Riverwater Partners LLC | 105,977 | $302,034 | 0.22% |
Granahan Investment Management | 1,925,398 | $5,487,384 | 0.22% |
HEARTLAND ADVISORS INC | 1,200,000 | $3,420,000 | 0.19% |